1. Romaniuk, A., Lyndin, M., Sikora, V., Lyndina, Y. & Panasovska, K. Histological and immunohistochemical features of medullary breast cancer. Folia Med. Cracov. 55, 41–48 (2015).
2. Honrado, E., Benítez, J. & Palacios, J. Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit. Rev. Oncol. Hematol. 59, 27–39, (2006).
3. Budzik, M. P. et al. Medullary breast cancer is a predominantly triple-negative breast cancer—histopathological analysis and comparison with invasive ductal breast cancer. Arch. Med Sci. 18, 432–439, (2019).
4. Dieci, M. V., Orvieto, E., Dominici, M., Conte, P. & Guarneri, V. Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist 19, 805–813, (2014).
5. Flucke, U. et al. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathol. 56, 852–859, (2010).